MRC Clinical Trials Unit at UCL
Menu
  • Home
  • About
    • Our Structure
      Our Staff
      History
      Our Environmental Commitment
  • News
  • Our Research
    • Cancer
      REFINE Add-Aspirin FOCUS4 STAMPEDE RAMPART STOPCAP M1 UKCTOCS Open Studies Past Studies
      Infections
      Studies by Research Area
      Neurodegenerative Diseases
      OCTOPUS ACORD collaboration
      Methodology
      Design Conduct Analysis Meta-analysis Software
      Other Research & Policy
      Studies in other areas Briefing Papers Data Sharing Regulatory information, Toolkits & Templates Publications Our podcast
  • Studies
    • All Studies
      Studies Search
  • Patients & Public
    • About Clinical Trials
      What is a clinical trial? What is a randomised clinical trial? What is an observational study? How do we make sure a trial is safe? How is a trial designed and run? What happens at the end of a trial?
      Taking Part in a Clinical Trial
      How can you take part in a trial? What questions should you ask before participating in a trial?
      Patient and Public Involvement
      About our PPI group PPI Resources
  • Education & Capacity Building
    • Enhancing skills of trial teams we work with across the globe
      Improving the clinical trials ecosystem
      Postgraduate Taught Courses
      Postgraduate Research Training
      NIHR Associate Principal Investigator (PI) Scheme
  • Careers
    • Our Vacancies
      Meet Our People
      Our Benefits
  • Contact

Studies in COVID-19

We are working on developing several studies looking at COVID-19.

ACTT-EU/UK

Adaptive COVID-19 Treatment Trial in the EU & UK (ACTT-EU/UK) - A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalised Adults

CoroNerve

A collaborative initiative to describe the neurological features of COVID-19

COVAC1

A first-in-human clinical trial to assess the safety and immunogenicity of a self-amplifying ribonucleic acid (saRNA) vaccine encoding the S glycoprotein of SARS-CoV-2, the causative agent of COVID 19

ICOS

An International Observational Study of Outpatients with SARS-CoV-2 Infection

ITAC

An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Hospitalized Patients at Onset of Clinical Progression of COVID-19

TICO/ACTIV-3/INSIGHT-014

Does giving patients hospitalised with COVID-19 a synthetically made antibody that blocks the virus make them get better more quickly?

  1. Home
  2. Our Research
  3. Infections
  4. Studies by Research Area
  5. COVID-19

Contact Us

MRC Clinical Trials Unit at UCL
90 High Holborn
London
WC1V 6LJ

Quick links

  • News
  • Contact
  • Glossary
  • Cookies
  • Privacy

Social pages

  • twitter
  • vimeo
  • soundcloud
  • © 2023
  • Glossary
  • Sitemap
  • Accessibility
  • Cookies
  • Privacy
  • Page last updated: 26-Mar-2020 22:04